2,3-二羟基喹啉

2,3-Dihydroxyquinoxaline

产品编号.: A804190 CAS号: 15804-19-0
分子式: C8H6N2O2 分子量: 162.1454
纯度: 98% MDL NO.:

中文名称:2,3-二羟基喹啉
CAS号:15804-19-0
中文别名:2,3-二羟基喹啉;2,3-二羟基喹喔啉;(4S,5R)-2-(4-甲氧基苯基)-4-苯基-3,5-恶唑烷二羧酸3-叔丁酯;1,4-二氢-2,3-喹喔啉二酮;2,3-Dihydroxyquinoxaline 2,3-二羟基喹喔啉;喹喔啉-2,3(1H,4H)-二酮;2,3(1H,4H)-喹喔啉二酮;喹喔啉-2,3-二羟基
英文名称:2,3-Dihydroxyquinoxaline
英文别名:Quinoxaline-2,3(1H,4H)-dione;2,3-Quinoxalinediol;1,4-Dihydro-2,3-quinoxalinedione;2,3-Dihydroxyquinoxaline;2,3-Quinoxalinedione, 1,4-dihydro-;Quinoxaline-2,3-diol;2,3(1H,4H)-Quinoxalinedione;2,3-Dihydroxyphenpiazine;1,4-dihydroquinoxaline-2,3-dione;Quinoxaline, 2,3-dihydroxy-;APO55IZ9E1;1,2,3,4-tetrahydroquinoxaline-2,3-dione;2,3[1H,4H]-Quinoxalinedione;ABJFBJGGLJVMAQ-UHFFFAOYSA-N;1,4-Dihydro-quinoxaline-2,3-dione;1,3-q;UNII-APO55IZ9E1;KSC-11-207-7;CIS-11-EICOSENOICACIDMETHYLESTER;MLS000681641;10.14272/ABJFBJGGLJVMAQ-UHFFFAOYSA-N.2;dihydroxy quinoxaline;CCG-49235;CS-0012607;KUC106696N;2(1H), 3(4H)-QUINOXALINEDIONE;1,4-dihydroquinoxaline-2,3-dione;Quinoxaline-2,3(1H,4H)-dione;MFCD00006723;EINECS 239-901-0;NSC 8698;SR-01000391115-2;NSC-9431;BB 0258963;NCGC00245941-01;NCGC00245941-01;hydroxyquinoxalone;hydroxyquinoxalone;SMR000312325;SMR000312325;doi:10.14272/ABJFBJGGLJVMAQ-UHFFFAOYSA-N.2;doi:10.14272/ABJFBJGGLJVMAQ-UHFFFAOYSA-N.2;F11637;F11637;NSC-8698;NSC-8698;10.14272/ABJFBJGGLJVMAQ-UHFFFAOYSA-N.1;10.14272/ABJFBJGGLJVMAQ-UHFFFAOYSA-N.1;10.14272/ABJFBJGGLJVMAQ-UHFFFAOYSA-N.3;10.14272/ABJFBJGGLJVMAQ-UHFFFAOYSA-N.3;USAF EK-6232;USAF EK-6232;2,3-Dihydroxyquinoxaline, 98%;2,3-Dihydroxyquinoxaline, 98%;AA-516/30054034;AA-516/30054034;doi:10.14272/ABJFBJGGLJVMAQ-UHFFFAOYSA-N.3;doi:10.14272/ABJFBJGGLJVMAQ-UHFFFAOYSA-N.3;EN300-34388;EN300-34388;2,3(1H, 4H)-Quinoxalinedione;2,3(1H, 4H)-Quinoxalinedione;NSC8698;NSC8698;A809895;A809895;1,4-Dihydro quinoxaline-2,3-dione;1,4-Dihydro quinoxaline-2,3-dione;AKOS000503008;AKOS000503008;Quinoxalin-2,3(1H,4H)-Dione;Quinoxalin-2,3(1H,4H)-Dione;2,3-dihydroxy quinoxaline;2,3-dihydroxy quinoxaline;F0266-0994;F0266-0994;BDBM50008752;BDBM50008752;2,3-QUINOXALINEDIOL;2,3-QUINOXALINEDIOL;NS00025139;NS00025139;15804-19-0;15804-19-0;AM20070315;AM20070315;SCHEMBL239920;SCHEMBL239920;6287-20-3;6287-20-3;EU-0000335;EU-0000335;InChI=1/C8H6N2O2/c11-7-8(12)10-6-4-2-1-3-5(6)9-7/h1-4H,(H,9,11)(H,10,12;InChI=1/C8H6N2O2/c11-7-8(12)10-6-4-2-1-3-5(6)9-7/h1-4H,(H,9,11)(H,10,12;W10297;W10297;HMS2750H11;HMS2750H11;HY-20803;HY-20803;WLN: T66 BN ENJ CQ DQ;WLN: T66 BN ENJ CQ DQ;AI3-03736;AI3-03736;propaquizafop TP3;propaquizafop TP3;Quinoxaline,3-dihydroxy-;Quinoxaline,3-dihydroxy-;AKOS001280678;AKOS001280678;SR-01000391115-1;SR-01000391115-1;D1010;FT-0609673;D1010;1,3-quinoxalinedione;FT-0609673;BB 0242095;SR-01000391115;1,3-quinoxalinedione;Z199538190;BB 0242095;FT-0691401;SR-01000391115;doi:10.14272/ABJFBJGGLJVMAQ-UHFFFAOYSA-N.1;Z199538190;FT-0609674;FT-0691401;SY049830;doi:10.14272/ABJFBJGGLJVMAQ-UHFFFAOYSA-N.1;AB06251;FT-0609674;W-107998;SY049830;CHEMBL282672;AB06251;DTXSID9065946;W-107998;PD195935;CHEMBL282672;NSC9431;DTXSID9065946;PD195935;NSC9431
EINEC:8698
分子式:C8H6N2O2
分子量:162.15
搜索质检报告(COA)
搜索MSDS
已经到最底了
批量搜索 关闭
批处理可以通过CAS号,CAS号,每行一个搜索
...

2,3-二羟基喹啉
Quinoxaline-2,3(1H,4H)-dione;2,3-Quinoxalinediol;1,4-Dihydro-2,3-quinoxalinedione;2,3-Dihydroxyquinoxaline;2,3-Quinoxalinedione, 1,4-dihydro-;Quinoxaline-2,3-diol;2,3(1H,4H)-Quinoxalinedione;2,3-Dihydroxyphenpiazine;1,4-dihydroquinoxaline-2,3-dione;Quinoxaline, 2,3-dihydroxy-;APO55IZ9E1;1,2,3,4-tetrahydroquinoxaline-2,3-dione;2,3[1H,4H]-Quinoxalinedione;ABJFBJGGLJVMAQ-UHFFFAOYSA-N;1,4-Dihydro-quinoxaline-2,3-dione;1,3-q;UNII-APO55IZ9E1;KSC-11-207-7;CIS-11-EICOSENOICACIDMETHYLESTER;MLS000681641;10.14272/ABJFBJGGLJVMAQ-UHFFFAOYSA-N.2;dihydroxy quinoxaline;CCG-49235;CS-0012607;KUC106696N;2(1H), 3(4H)-QUINOXALINEDIONE;1,4-dihydroquinoxaline-2,3-dione;Quinoxaline-2,3(1H,4H)-dione;MFCD00006723;EINECS 239-901-0;NSC 8698;SR-01000391115-2;NSC-9431;BB 0258963;NCGC00245941-01;NCGC00245941-01;hydroxyquinoxalone;hydroxyquinoxalone;SMR000312325;SMR000312325;doi:10.14272/ABJFBJGGLJVMAQ-UHFFFAOYSA-N.2;doi:10.14272/ABJFBJGGLJVMAQ-UHFFFAOYSA-N.2;F11637;F11637;NSC-8698;NSC-8698;10.14272/ABJFBJGGLJVMAQ-UHFFFAOYSA-N.1;10.14272/ABJFBJGGLJVMAQ-UHFFFAOYSA-N.1;10.14272/ABJFBJGGLJVMAQ-UHFFFAOYSA-N.3;10.14272/ABJFBJGGLJVMAQ-UHFFFAOYSA-N.3;USAF EK-6232;USAF EK-6232;2,3-Dihydroxyquinoxaline, 98%;2,3-Dihydroxyquinoxaline, 98%;AA-516/30054034;AA-516/30054034;doi:10.14272/ABJFBJGGLJVMAQ-UHFFFAOYSA-N.3;doi:10.14272/ABJFBJGGLJVMAQ-UHFFFAOYSA-N.3;EN300-34388;EN300-34388;2,3(1H, 4H)-Quinoxalinedione;2,3(1H, 4H)-Quinoxalinedione;NSC8698;NSC8698;A809895;A809895;1,4-Dihydro quinoxaline-2,3-dione;1,4-Dihydro quinoxaline-2,3-dione;AKOS000503008;AKOS000503008;Quinoxalin-2,3(1H,4H)-Dione;Quinoxalin-2,3(1H,4H)-Dione;2,3-dihydroxy quinoxaline;2,3-dihydroxy quinoxaline;F0266-0994;F0266-0994;BDBM50008752;BDBM50008752;2,3-QUINOXALINEDIOL;2,3-QUINOXALINEDIOL;NS00025139;NS00025139;15804-19-0;15804-19-0;AM20070315;AM20070315;SCHEMBL239920;SCHEMBL239920;6287-20-3;6287-20-3;EU-0000335;EU-0000335;InChI=1/C8H6N2O2/c11-7-8(12)10-6-4-2-1-3-5(6)9-7/h1-4H,(H,9,11)(H,10,12;InChI=1/C8H6N2O2/c11-7-8(12)10-6-4-2-1-3-5(6)9-7/h1-4H,(H,9,11)(H,10,12;W10297;W10297;HMS2750H11;HMS2750H11;HY-20803;HY-20803;WLN: T66 BN ENJ CQ DQ;WLN: T66 BN ENJ CQ DQ;AI3-03736;AI3-03736;propaquizafop TP3;propaquizafop TP3;Quinoxaline,3-dihydroxy-;Quinoxaline,3-dihydroxy-;AKOS001280678;AKOS001280678;SR-01000391115-1;SR-01000391115-1;D1010;FT-0609673;D1010;1,3-quinoxalinedione;FT-0609673;BB 0242095;SR-01000391115;1,3-quinoxalinedione;Z199538190;BB 0242095;FT-0691401;SR-01000391115;doi:10.14272/ABJFBJGGLJVMAQ-UHFFFAOYSA-N.1;Z199538190;FT-0609674;FT-0691401;SY049830;doi:10.14272/ABJFBJGGLJVMAQ-UHFFFAOYSA-N.1;AB06251;FT-0609674;W-107998;SY049830;CHEMBL282672;AB06251;DTXSID9065946;W-107998;PD195935;CHEMBL282672;NSC9431;DTXSID9065946;PD195935;NSC9431